Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-039352
Filing Date
2020-06-29
Accepted
2020-06-29 21:21:20
Documents
1
Period of Report
2020-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 24076
  Complete submission text file 0001209191-20-039352.txt   25595
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVE., 14TH FLOOR CAMBRIDGE MA 02139
Business Address
Mahadevia Ankit (Reporting) CIK: 0001720974 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 20999937